Brief: Theradiag Expects 2020 Revenue To Be Negatively Impacted By Covid-19
22/04/2020 17:23
April 22 (Reuters) - THERADIAG SA ALTHE.PA :
* COMMITTED TO FIGHT COVID-19 AND REVIEWS POTENTIAL IMPACT
FOR
2020
* HAS STARTED DISTRIBUTION BUT OVERALL DEVELOPMENT OF
COVID-19
SEROLOGICAL TESTS, TESTS OF HIGH-QUALITY, THAT ALSO FACILITATE
AND SECURE NATIONAL SUPPLIES
* THERADIAG IS EXPECTING 2020 REVENUE TO PROBABLY BE
NEGATIVELY
IMPACTED BY AROUND 10%
* SINCE BEGINNING OF WEEK OF APRIL 20, COMPANY HAS INITIATED
PROCESS OF VALIDATION OF SEROLOGICAL TEST KITS AT NATIONAL
REFERENCE CENTRE FOR RESPIRATORY INFECTION VIRUSES IN PARIS
* IT IS TOO EARLY TO SAY WHETHER COMPANY’S CONTRIBUTION TO
COVID-19 SEROLOGY TESTING OR INVOLVEMENT IN BIOTHERAPY DOSAGE
WILL HAVE EFFECT ON 2020 REVENUE
Source text for Eikon: ID:nBw96SfDya
Further company coverage: ALTHE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))